Polarityte Performance

PTEDelisted Stock  USD 0.07  0.01  10.29%   
The company holds a Beta of -1.83, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Polarityte are expected to decrease by larger amounts. On the other hand, during market turmoil, Polarityte is expected to outperform it. Polarityte right now holds a risk of 0.0%. Please check Polarityte total risk alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if Polarityte will be following its historical price patterns.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Polarityte has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Polarityte is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Begin Period Cash Flow19.4 M
  

Polarityte Relative Risk vs. Return Landscape

If you would invest  7.50  in Polarityte on August 28, 2024 and sell it today you would earn a total of  0.00  from holding Polarityte or generate 0.0% return on investment over 90 days. Polarityte is generating negative expected returns assuming volatility of 0.0% on return distribution over 90 days investment horizon. In other words, 0% of stocks are less volatile than Polarityte, and above 99% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  

Polarityte Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Polarityte's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Polarityte, and traders can use it to determine the average amount a Polarityte's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
PTE
Based on monthly moving average Polarityte is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Polarityte by adding Polarityte to a well-diversified portfolio.

Polarityte Fundamentals Growth

Polarityte Stock prices reflect investors' perceptions of the future prospects and financial health of Polarityte, and Polarityte fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Polarityte Stock performance.

About Polarityte Performance

By analyzing Polarityte's fundamental ratios, stakeholders can gain valuable insights into Polarityte's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Polarityte has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Polarityte has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
PolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car PTE 11000, an allogenic, biologically active dressing for use in wound care and aesthetics to accelerate healing of skin and other tissue regeneration products. Polarityte operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people.

Things to note about Polarityte performance evaluation

Checking the ongoing alerts about Polarityte for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Polarityte help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Polarityte is not yet fully synchronised with the market data
Polarityte has some characteristics of a very speculative penny stock
Polarityte has a very high chance of going through financial distress in the upcoming years
The company reported the last year's revenue of 814 K. Reported Net Loss for the year was (7.83 M) with profit before taxes, overhead, and interest of 198 K.
Polarityte has about 20.88 M in cash with (22.6 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.78, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Evaluating Polarityte's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Polarityte's stock performance include:
  • Analyzing Polarityte's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Polarityte's stock is overvalued or undervalued compared to its peers.
  • Examining Polarityte's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Polarityte's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Polarityte's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Polarityte's stock. These opinions can provide insight into Polarityte's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Polarityte's stock performance is not an exact science, and many factors can impact Polarityte's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Consideration for investing in Polarityte Stock

If you are still planning to invest in Polarityte check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Polarityte's history and understand the potential risks before investing.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Share Portfolio
Track or share privately all of your investments from the convenience of any device
CEOs Directory
Screen CEOs from public companies around the world
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments